Journal profile · Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Journal of Cellular and Molecular Medicine
ISSN 1582-4934 · Wiley-Blackwell · United Kingdom
Journal of Cellular and Molecular Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.68; fully open access; APC about USD 5,730; median 153 days to acceptance (108 articles, last 24 months); community-reported acceptance: about 50%; 712 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Journal of Cellular and Molecular Medicine is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and RNA modifications and cancer, together about 29.8% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches. Please note that: Journal of Cellular and Molecular Medicine is online-only. Journal of Cellular and Molecular Medicine joined the Wiley Open Access publishing program of fully open access journals published by Wiley inJanuary 2013. For further information visit the Wiley Open Access website. Open Access and Copyright All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Copyright in any research article published by Journal of Cellular and Molecular Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Read more on Open Access Licence and Copyright here.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Editor-in-chief Stefan N. ConstantinescuPublisher website
Editorial board by country: 30 in mainland China (about 14%); most named United States 76, Mainland China 30, Romania 16, United Kingdom 14, Germany 11 (215 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology12.1%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology9.8%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology7.9%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology6.7%
- Mesenchymal stem cell researchMedicine4.5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.4%
- Autophagy in Disease and TherapyMedicine4.3%
- Ferroptosis and cancer prognosisMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Cell Biology | Zone 3 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2021 edition (medium risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.68LetPub ·
- CiteScore 2026-06
- 6.9LetPub ·
- SJR 2026-06
- 1.14LetPub ·
- SNIP 2026-06
- 0.92LetPub ·
- h-index
- 108LetPub ·
- h-index
- 187OpenAlex ·
- i10-index
- 6,973OpenAlex ·
- 2-year mean citedness
- 4.54OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 613LetPub ·
Articles by year OpenAlex count · 10,292 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 387 | 387 | 172 |
| 2025 | 712 | 712 | 1,990 |
| 2024 | 795 | 795 | 6,446 |
| 2023 | 486 | 486 | 6,623 |
| 2022 | 531 | 531 | 8,759 |
| 2021 | 946 | 946 | 23,160 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
153 daysMedian, submission to acceptance · P25–P75 111 days – 211 days
- Acceptance to online
- median 20 days (108 articles)
- Submission to online
- median 187 days
- Sample
- 108 articles with submission and acceptance dates (1,250 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 28 weeksLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to publication (journal-reported)
- about 28 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 5,730 / GBP 3,720 / EUR 5,310 | Yes | CC BY | |
| OpenAlex | USD 5,210 / EUR 4,830 / GBP 3,380 | — | — | |
| LetPub | USD 4,510 / GBP 2,920 / EUR 4,180 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted12, with length limits
- commentaryOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- editorialOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- letterOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- letter to the editorOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- opinionOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- original articleOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- original articlesOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- research paperOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- reviewOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …Length not stated
- reviewsReviews: Cover Letter – The cover letter must include a list of relevant articles published by the corresponding/most senior author in the last 3-5 years.Length not stated
- short communicationOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …main text ≤ 1,200 words
- short communicationsShort Communications: Cover Letter 1,200 words excluding title page, abstract, references, and figure legendsLength not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria: Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; Been involved in drafting the manuscript or revising it critically for important intellectual…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potent…
Source ↗Publisher website ·- Data availability
Data sharing expected; Data Availability Statement required for all accepted manuscripts. Model summary
Data Sharing, Data Availability, and Data Reporting This journal expects data sharing. All accepted manuscripts are required to publish a Data Availability Statement to confirm the presence or absence of shared data.
Source ↗Publisher website ·- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Once your manuscript has been submitted, the editorial staff will check the formatting of the files to ensure they are in adherence with the above. The Editor-in-Chief (EiC) then evaluates it to check whether it fits with the aims and scope. …
Source ↗Publisher website ·- License & copyright Open Access and Copyright
All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Source ↗Publisher website ·- Open access Open Access and Copyright
All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Once your manuscript has been submitted, the editorial staff will check the formatting of the files to ensure they are in adherence with the above. The Editor-in-Chief (EiC) then evaluates it to check whether it fits with the aims and scope. Papers will only be sent to…
Source ↗Publisher website ·- Preprints
Preprints considered for review; authors may post submitted version to a preprint server at any time. Model summary
Preprint policy: Please find the Wiley preprint policy here. The Journal of Cellular and Molecular Medicine will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1582-4934
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Cellular and Molecular Medicine
What CAS zone is Journal of Cellular and Molecular Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cellular and Molecular Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cellular and Molecular Medicine?
The latest impact factor listed by LetPub is 4.68; CiteScore 6.9, h-index 187.
How long does peer review take at Journal of Cellular and Molecular Medicine?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 153 days (interquartile range 111–211 days); authors report an average review time of about 28 weeks; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Cellular and Molecular Medicine based?
Of the 215 board members whose country the journal's board page names, 30 (about 14%) are in mainland China; the countries named most often are United States (76), Mainland China (30) and Romania (16). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cellular and Molecular Medicine?
According to LetPub and DOAJ records, Journal of Cellular and Molecular Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE and PubMed; that list has not been checked against each database.
Is Journal of Cellular and Molecular Medicine open access, and what is the APC?
Journal of Cellular and Molecular Medicine is a fully open-access journal. APC about USD 5,730.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .